Production of radionuclides
News from the European project ENSAR 2
11.10.21
Initiated in March 2016 to strengthen links and collaborations between scientists working on nuclear energy, ENSAR 2 ended in August 2021. GIP ARRONAX participated in the activities on radioisotopes for …
PRISMAP : building a European network for medical radionuclides
21.09.21
PRISMAP – The European medical radionuclides programme sets out to substantially change the European landscape for novel and emerging medical radionuclides. The GIP ARRONAX takes part of PRISMAP, the European …
Chemistry and radiopharmacy
Marie and the chemistry of ruthenium
06.12.21
In the fall of 2021, Marie Théry started a thesis at GIP ARRONAX to study the chemistry of Auger electron emitting elements, especially ruthenium. The first time Marie set foot …
Vers de nouveaux outils diagnostiques de la maladie d’Alzheimer
18.11.21
Une équipe de recherche du laboratoire Subatech (UMR 6457 IMT Atlantique/CNRS/IN2P3 /Université de Nantes) va participer, en lien avec le GIP ARRONAX, au programme européen EuroNanoMed (Action ERA-Net Cofund) sur …
Pre-clinical experimentation and clinical research
End of Ipsen clinical trial at 177lu-OPS201
18.08.20
Launched in November 2018 in Nantes, France, the phase 1-2 study evaluating the safety, tolerability and efficacy of 177lu-OPS201 in patients with somatostatin receptor-positive neuroendocrine tumors is nearing completion. The …
A COST Action dedicated to the development of astatine therapy
14.05.20
Resulting from a common will of the CRCINA, Arronax and the University hospital of Nantes, the project submitted by Jean-François Gestin to set up an international clinical network in Europe …
Non-living and living matter exposed to radiations
Nantes at the forefront of research on the FLASH effect
07.04.22
Researchers from the ICO (Institut de Cancérologie de l'Ouest), Subatech laboratory and GIP ARRONAX have been collaborating for years to better understand the FLASH effect observed during external irradiation of …
Mohammad and radiolysis applied to medicine
04.11.21
A few years after his thesis in radiochemistry at the Subatech laboratory, Mohammad Ghalei returned to Nantes to develop the radiolysis research carried out at GIP ARRONAX. Mohammad Ghalei's experiments …
Training activities
A gathering of world-renowned experts in radiopharmaceutical sciences in Nantes
03.05.22
From 29th May to 2nd June 2022, around 400 researchers from the world over will gather at the Cité des Congrès in Nantes for the 24th edition of the “International …
See you at Gen2Bio 2022 symposium
23.02.22
The annual biotech symposium organized by Biogenouest will be held on March 24 and 25, 2022 in La Baule (France) and online. Arronax Nantes will attend this meeting, and its …